Furthermore, Oncomine analysis of cancer vs normal samples in different patient datasets revealed that PKMYT1 expression was significantly higher in invasive breast carcinoma, invasive lobular breast carcinoma, invasive ductal breast carcinoma, male breast carcinoma, medullary breast carcinoma, mucinous breast carcinoma, ductal breast carcinoma in situ and tubular breast carcinoma (Figure 2) (Table 1). Here, PKMYT1 is linked to ductal breast carcinoma in situ.